Abvc Biopharma (ABVC) EBIT Margin (QoQ) (2010 - 2024)
Powered by 
Analysis
Abvc Biopharma (ABVC) EBIT Margin (QoQ) (2010 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -3.58 Mn |
| Sep 30, 2024 | 65,658.00 |
| Jun 30, 2024 | 23.48 Mn |
| Mar 31, 2024 | -21.19 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | -3.44 Mn |
| Mar 31, 2023 | -95,413.00 |
| Dec 31, 2022 | 825,901.00 |
| Sep 30, 2022 | -813,670.00 |
| Jun 30, 2022 | 2.36 Mn |
| Mar 31, 2022 | -4.13 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 448,360.00 |
| Jun 30, 2021 | -599,802.00 |
| Mar 31, 2021 | 732,324.00 |
| Dec 31, 2020 | -668,313.00 |
| Sep 30, 2020 | -58,904.00 |
| Jun 30, 2020 | 95,966.00 |
| Mar 31, 2020 | -36,257.00 |